
What’s next for Cassava Sciences, and Cartesian Therapeutics has a novel excuse for dodgy data
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Taking